Dr. Casanova is a member of the National Academy of Sciences of the USA, an investigator of the Howard Hughes Medical Institute, and a Professor at the Rockefeller University in New York. He is a world renowned immunologist and geneticist, with a research interest in human genetic diseases that compromise immunity to infectious agents. His studies led to pivotal findings that guide molecular diagnosis of diseases and serve as foundations for developing new therapies. Elixiron Immunotherapeutics aspires to discover new drugs based on Dr. Casanova’s “from human disease to therapy” approach.
Dr. Casanova heads the St. Giles Laboratory of Human Genetics of Infectious Disease at Rockefeller University, New York, USA. He is also the Senior Attending Physician at the Rockefeller University Hospital. He received numerous prestigious awards throughout his career, including the Professor Lucien Dautrebande Pathophysiology Foundation Prize (2004), Richard Lounsbery Award (2008), E. Mead Johnson Award from the Society for Pediatric Research (2010), InBev-Baillet Latour Health Prize (2011), Ilse & Helmut Wachter Foundation Award and the Milstein Award (2012), Robert Koch Prize and the Sanofi-Institut Pasteur Award (2014), election to the National Academy of Sciences of the USA (2015), AAI-Steinman Award for human immunology research (2017), and Distinguished Service Award from Clinical Immunology Society (2018).